Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQUIPO quinagolide for prevention of OHSS
2006-000415-15Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of quinagolide in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Presence of moderate/severe early ovarian hyperstimulation syndrome. Started Apr 2006; status: completed.
02
Drugs
quinagolide
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on 2006-000415-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000415-15.